Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza
Background: Whether the enteric absorption of the neuraminidase inhibitor oseltamivir is
impaired in critically ill patients is unknown. We documented the pharmacokinetic profile of …
impaired in critically ill patients is unknown. We documented the pharmacokinetic profile of …
[HTML][HTML] Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza
WRJ Taylor, BN Thinh, GT Anh, P Horby, H Wertheim… - PLoS …, 2008 - journals.plos.org
In the absence of a parenteral drug, oral oseltamivir is currently recommended by the WHO
for treating H5N1 influenza. Whether oseltamivir absorption is adequate in severe influenza …
for treating H5N1 influenza. Whether oseltamivir absorption is adequate in severe influenza …
Oseltamivir dosing in critically ill patients with severe influenza
AH Flannery… - Annals of …, 2014 - journals.sagepub.com
Objective: To evaluate the literature for published reports regarding the efficacy of standard
versus higher dosing of oseltamivir in critically ill patients with severe influenza. Data …
versus higher dosing of oseltamivir in critically ill patients with severe influenza. Data …
Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A
Objectives The impact of oseltamivir on mortality in critically ill patients with 2009 pandemic
influenza A (2009 H1N1) is not clear. The main objective of this study was to investigate the …
influenza A (2009 H1N1) is not clear. The main objective of this study was to investigate the …
Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill …
F Lemaitre, CE Luyt, F Roullet-Renoleau… - Therapeutic drug …, 2012 - journals.lww.com
Purpose The neuraminidase inhibitor oseltamivir is a recommended treatment for influenza
A (H1N1) infection. In rare cases, some patients develop influenza-associated multiple …
A (H1N1) infection. In rare cases, some patients develop influenza-associated multiple …
A prospective intervention study on higher-dose oseltamivir treatment in adults hospitalized with influenza a and B infections
Background. It is unclear if higher-dose oseltamivir provides benefit beyond the standard
dose in influenza patients who require hospitalization. Methods. A prospective intervention …
dose in influenza patients who require hospitalization. Methods. A prospective intervention …
Comparison of high-dose versus standard dose oseltamivir in critically ill patients with influenza
ZR Noel, MLT Bastin, AA Montgomery… - Journal of intensive …, 2017 - journals.sagepub.com
Background: Limited data support high-dose oseltamivir in critically ill patients with
influenza. In several recent influenza seasons, there were oseltamivir drug shortages …
influenza. In several recent influenza seasons, there were oseltamivir drug shortages …
[HTML][HTML] Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics
Oseltamivir is the ester-type prodrug of the neuraminidase inhibitor oseltamivir carboxylate.
It has been shown to be an effective treatment for both seasonal influenza and the recent …
It has been shown to be an effective treatment for both seasonal influenza and the recent …
Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Critically I ll Patients Receiving Continuous Venovenous Hemodialysis and/or Extracorporeal …
RF Eyler, M Heung, M Pleva… - … : The Journal of …, 2012 - Wiley Online Library
Study Objective To investigate oseltamivir and oseltamivir carboxylate pharmacokinetics in
critically ill patients who were receiving continuous venovenous hemodialysis (CVVHD) …
critically ill patients who were receiving continuous venovenous hemodialysis (CVVHD) …
Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study
V Hiba, M Chowers, I Levi-Vinograd… - Journal of …, 2011 - academic.oup.com
Background We assessed the association between early oseltamivir treatment and influenza
complications in hospitalized patients. Methods A retrospective cohort study, including …
complications in hospitalized patients. Methods A retrospective cohort study, including …
Related searches
- enteric absorption pharmacokinetics of oseltamivir
- venovenous hemodialysis pharmacokinetics of oseltamivir
- membrane oxygenation pharmacokinetics of oseltamivir
- venovenous hemodiafiltration oseltamivir carboxylate
- oseltamivir treatment pandemic influenza
- oseltamivir dosing severe influenza
- pharmacokinetics and tolerability patients on haemodialysis
- membrane oxygenation oseltamivir carboxylate
- venovenous hemodialysis oseltamivir carboxylate